Darzalex

Darzalex ATC Classification

daratumumab

Manufacturer:

Cilag AG

Distributor:

Johnson & Johnson

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

ATC Classification

L01FC01 - daratumumab ; Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.

Sign up for Free to Continue Reading

Continue with Google

Sign up with email

Already a member? Sign in